JP2003500171A5 - - Google Patents

Download PDF

Info

Publication number
JP2003500171A5
JP2003500171A5 JP2000620966A JP2000620966A JP2003500171A5 JP 2003500171 A5 JP2003500171 A5 JP 2003500171A5 JP 2000620966 A JP2000620966 A JP 2000620966A JP 2000620966 A JP2000620966 A JP 2000620966A JP 2003500171 A5 JP2003500171 A5 JP 2003500171A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000620966A
Other languages
Japanese (ja)
Other versions
JP2003500171A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/015139 external-priority patent/WO2000072856A1/fr
Publication of JP2003500171A publication Critical patent/JP2003500171A/ja
Publication of JP2003500171A5 publication Critical patent/JP2003500171A5/ja
Pending legal-status Critical Current

Links

JP2000620966A 1999-06-01 2000-06-01 より炎症性応答の少ないフィブリンシーラントおよびこれを用いる方法 Pending JP2003500171A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13690399P 1999-06-01 1999-06-01
US60/136,903 1999-06-01
PCT/US2000/015139 WO2000072856A1 (fr) 1999-06-01 2000-06-01 Agents d'obturation a base de fibrine declenchant une moindre reponse inflammatoire; methodes d'utilisation

Publications (2)

Publication Number Publication Date
JP2003500171A JP2003500171A (ja) 2003-01-07
JP2003500171A5 true JP2003500171A5 (fr) 2007-06-14

Family

ID=22474935

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000620966A Pending JP2003500171A (ja) 1999-06-01 2000-06-01 より炎症性応答の少ないフィブリンシーラントおよびこれを用いる方法

Country Status (7)

Country Link
EP (1) EP1223955A1 (fr)
JP (1) JP2003500171A (fr)
AU (1) AU771328B2 (fr)
CA (1) CA2373706A1 (fr)
NO (1) NO20015760L (fr)
NZ (1) NZ515581A (fr)
WO (1) WO2000072856A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278189A (en) * 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
US5230996A (en) * 1990-06-04 1993-07-27 Therapy 2000 Use of ascorbate and tranexamic acid solution for organ and blood vessel treatment prior to transplantation
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
WO1993008818A1 (fr) * 1991-11-07 1993-05-13 The University Of Southern California Compositions et procedes permettant d'eviter la formation d'adherences
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法

Similar Documents

Publication Publication Date Title
BE2017C009I2 (fr)
BE2014C019I2 (fr)
BE2013C060I2 (fr)
BE2011C041I2 (fr)
BE2011C032I2 (fr)
BE2010C009I2 (fr)
AU2000236815A8 (fr)
BRPI0110940B8 (fr)
BE2010C040I2 (fr)
BE2014C025I2 (fr)
BRPI0003419A (fr)
CN3135584S (fr)
CN3139842S (fr)
AU2001294354A8 (fr)
AU2001273056A2 (fr)
AU2000280388A8 (fr)
AU2000280296A8 (fr)
AU2000278563A8 (fr)
AU2000278560A8 (fr)
BY5592C1 (fr)
CL45687B (fr)
CN3134543S (fr)
CN3134893S (fr)
CN3135489S (fr)
CN3145472S (fr)